Embolus Extravasation

NING LIN,MINGCHANG LI,ROBERT M. FRIEDLANDER

DOI: https://doi.org/10.1227/01.neu.0000386970.79323.cd

IF: 5.315

2010-01-01

Neurosurgery

Abstract:Patency of cerebral vasculature is essential to normal brain functions. Occlusion of large intracranial arteries can lead to devastating consequences of cerebral ischemia and infarction, whereas small vessel occlusion caused by microemboli was found to be frequently associated with dementia and cognitive decline.1,2 A number of clinical studies with Transcranial Doppler Ultrasonography have demonstrated that silent embolic events in the brain are common especially in patients with carotid or aortic arch atherosclerotic disease.3,4 Throughout evolution, the body has developed effective counter-acting mechanisms, such as the fibrinolytic system, to degrade abnormally formed blood clots so as to ensure uninterrupted blood flow. However, these innate pathways seem less robust in terminal arterioles and capillaries due to smaller size of the microvessels and low velocity of blood flow in the capillary bed.5–7 Are there alternative means to efficiently re-canalize the microvasculature in the brain? This question was answered by a most recent study published in Nature, 8 in which a group of scientists from Northwestern University School of Medicine described a direct extravasation pathway that clears small emboli from cerebral microvessels. The authors used mice expressing endothelial-specific green fluorescent protein (Tie2-GFP) as subjects and developed a system of two-photon microscopy and electron microscopy to image the microvessels. They first observed that, after fluorescently-conjugated microemboli (8–20 μm) were infused through the carotid artery of a mouse, a substantial number (50–60%) were cleared within 2 hours, presumably by the fibrinolytic system and hemodynamic forces. However, the retained emboli were difficult to be washed off in the subsequent days and usually caused cessation of blood flow in the occluded microvessels. After extending the in vivo imaging interval, the authors found that, by day 6, many emboli were no longer located inside the vessel lumen and the blood flow had resumed. This process of extravasation seemed to start as early as 2 days after embolization and could last for 2 to 5 days (Figure, A). It frequently led to complete re-establishment of blood flow and sparing of the vessel (70–80%). These observations from in vivo imaging were confirmed by transmission electron microscopy where microemboli were found to have translocated outside of the vessel lumen (Figure, B).FIGURE: 1A. A fluorescently-conjugated microembolus was first enveloped by an endothelial membrane by Day 3, then extravasated from the microvessel by Day 5 (Adapted from Figure 2A of Lam et al). Figure 1B. Transmission electron microscopy showed extravasated fibrin clot (arrow heads) and patent vessel lumen (Adapted from Figure 1J of Lam et al). Figure 1C. Confocal images of synaptophysin immunoreactivity near an occluded microvessel (asterisk) showed dystrophic synapses (arrowhead) in aged mice (Adapted from Figure 4C of Lam et al).Next, the authors investigated the underlying mechanism by which embolic material was extravasated from the microvasculature. They observed that within 24 to 48 hours, the embolus was completely enveloped by an endothelial membrane projected from the adjacent endothelial wall. Then, the original endothelium underwent retraction via tight-junction disruption to allow the passage of the enclosed embolus (Figure, A). The newly-formed endothelial membrane covering the embolus made frequent contact and transient adhesion with the opposing endothelium, and eventually a new vessel lumen was established and blood flow resumed. Moreover, it was also demonstrated that matrix metalloproteinases (MMPs) were important mediators of the extravasation process, probably because of their proteolytic functions in the degradation of tight-junction and extracellular matrix, and that inhibition of these enzymes markedly decreased the rate of embolus extravasation. Furthermore, the authors reported that age was a significant factor on the efficiency of embolus removal and the severity of neuronal and vascular damage surrounding the occluded microvessel. While younger mice (4-month-old) were able to clear most microemboli and suffered no obvious vascular degeneration or neuronal injury, older mice (22-month-old) showed much less robust extravasating capability. Dystrophic synapses (Figure, C) and Caspase-3 immunoreactive peri-vascular cells were also frequently observed in older mice after embolus injection, suggesting that persistent microemboli could eventually lead to permanent capillary and neuronal loss in the brain. The delayed extravasation described in this paper is a new and independent mechanism by which occluded cerebral microvessels can be recanalized via translocation of the microemboli. It is especially useful to clear occluding materials not susceptible to fibrinolysis such as cholesterol or atherosclerotic fragments. It may also play an important role in neurodegenerative diseases and cerebral vasospasm.1,9,10 While the underlying genetic and molecular pathways are still unclear, the findings of this study provide additional insights into the microenvironment surrounding the cerebral vasculature in thromboembolic events. NING LIN MINGCHANG LI ROBERT M. FRIEDLANDER